Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Rectal Neoplasms 45 Colorectal Neoplasms 45 Carcinoma, Non-Small-Cell Lung 31 Esophageal Neoplasms 28 Esophageal Squamous Cell Carcinoma 24 Stomach Neoplasms 22 Lung Neoplasms 20 Pancreatic Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 18 Colonic Neoplasms 18 Sarcoma 16 Neoplasms 16 Adenocarcinoma Of Esophagus 15 Ovarian Neoplasms 14 Neoplasm Metastasis 14 Head and Neck Neoplasms 14 Carcinoma, Hepatocellular 14 Prostatic Neoplasms 13 Urinary Bladder Neoplasms 12 Uterine Cervical Neoplasms 10 Inflammatory Breast Neoplasms 9 Fallopian Tube Neoplasms 9 Osteosarcoma 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Recurrence 6 Multiple Myeloma 6

Interventions

Rituximab 99 Cyclophosphamide 63 fludarabine phosphate 55 Peripheral Blood Stem Cell Transplantation 52 Mycophenolic Acid 34 Whole-Body Irradiation 33 Bortezomib 33 ibrutinib 29 Dexamethasone 27 Tacrolimus 26 Cyclosporine 25 Busulfan 23 Etoposide 22 Melphalan 20 Filgrastim 20 zanubrutinib 18 Methotrexate 18 Lenalidomide 18 Antilymphocyte Serum 18 Radiotherapy 16 Bendamustine Hydrochloride 14 Sirolimus 13 Calcium Dobesilate 11 Flow Cytometry 10 Everolimus 10 venetoclax 9 ibritumomab tiuxetan 9 Prednisone 9 Indium 9 Cyclosporins 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Neoadjuvant Therapy × Clear all

NCT07259122 2025-12-02

ZBR in WM

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡